Analyzing Star Equity (NASDAQ:STRR) and IMRIS (OTCMKTS:IMRSQ)

Star Equity (NASDAQ:STRRGet Rating) and IMRIS (OTCMKTS:IMRSQGet Rating) are both multi-sector conglomerates companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, profitability, risk, institutional ownership and valuation.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Star Equity and IMRIS, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Star Equity 0 0 1 0 3.00
IMRIS 0 0 0 0 N/A

Earnings and Valuation

This table compares Star Equity and IMRIS’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Star Equity $106.56 million 0.14 -$2.98 million ($0.80) -1.24

IMRIS has lower revenue, but higher earnings than Star Equity.


This table compares Star Equity and IMRIS’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Star Equity -2.80% -29.99% -8.20%

Volatility and Risk

Star Equity has a beta of 0.37, indicating that its stock price is 63% less volatile than the S&P 500. Comparatively, IMRIS has a beta of -4.64, indicating that its stock price is 564% less volatile than the S&P 500.

Insider and Institutional Ownership

60.1% of Star Equity shares are held by institutional investors. 9.0% of Star Equity shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.


Star Equity beats IMRIS on 5 of the 8 factors compared between the two stocks.

Star Equity Company Profile (Get Rating)

Star Equity Holdings, Inc. provides healthcare solutions in the United States and internationally. It operates through four segments: Diagnostic Services, Diagnostic Imaging, Building and Construction, and Real Estate and Investments. The company offers imaging and monitoring services to healthcare providers; and contract diagnostic imaging, including computerized tomography (CT), magnetic resonance imaging, positron emission tomography (PET), PET/CT, and nuclear medicine and healthcare services to cardiologists, internal medicine physicians, family practice physicians, hospitals, IDNs, and federal institutions. It also develops, sells, and maintains solid-state gamma cameras; imaging systems, such as nuclear cardiac imaging systems and general purpose nuclear imaging systems to physician offices and hospitals; and offers camera maintenance contract services. In addition, it manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; and manages and finances real estate assets and investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut.

IMRIS Company Profile (Get Rating)

IMRIS, Inc. is engaged in the design, manufacture, and market of image guided therapy systems. Its IMRIS Surgical Theatre provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. The company was founded on May 18, 2005 and is headquartered in Winnipeg, Canada.

Receive News & Ratings for Star Equity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Star Equity and related companies with's FREE daily email newsletter.